Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

COSCIENS Biopharma Inc. (CSCIF) vs Longeveron Inc. (LGVN)

COSCIENS Biopharma Inc. and Longeveron Inc. are both Biotechnology companies. COSCIENS Biopharma Inc. and Longeveron Inc. are of similar size ($9.1M and $8.6M). Longeveron Inc. has negative trailing earnings, so its P/E is not meaningful; COSCIENS Biopharma Inc. trades at 1.0×. COSCIENS Biopharma Inc. grew revenue faster over the last twelve months: −3.02% against −42.7%. COSCIENS Biopharma Inc. has the higher net margin (75.1% vs −1,977.6%) and the higher return on invested capital (−40.6% vs −4,549.0%). Across the 17 metrics below, COSCIENS Biopharma Inc. leads on 13 and Longeveron Inc. on 4.

Valuation

Metric CSCIF LGVN Biotechnology median
P/E 0.97 n/m 7.88
P/S 0.73 7.43 11.47
P/B 0.43 0.85 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.13 0.09 10.73
Earnings yield 103.12% (352.31%) (28.84%)
Free cash flow yield (48.39%) (236.36%) (23.03%)

Profitability

Metric CSCIF LGVN Biotechnology median
Gross margin 46.48% 69.76% 65.16%
Operating margin (71.13%) (1,992.84%) 0.00%
Net margin 75.11% (1,977.59%) 0.00%
Free cash flow margin (40.36%) (1,755.69%) 0.00%
Return on equity 59.74% (203.61%) (57.72%)
Return on assets 28.24% (145.64%) (49.22%)
Return on invested capital (40.56%) (4,549.04%) 0.00%

Growth

Metric CSCIF LGVN Biotechnology median
Revenue growth (TTM) (3.02%) (42.74%) 5.64%
EPS growth (last fiscal year) 44.86% 50.76% —
Revenue growth, 5-year CAGR 15.47% (26.60%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CSCIF LGVN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.33 2.63 4.73
Net debt to EBITDA 0.78 0.20 0.96

Dividend

Metric CSCIF LGVN Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric CSCIF LGVN Biotechnology median
Market cap 8.57m 9.12m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack